RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, InvestingPro analysis suggests the stock is trading above its Fair Value.

In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price

Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and households, the Swiss lender's CEO, Sergio Ermotti, said on Thursday.

UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price target to EUR266.00 from the previous EUR248.00. The stock, currently trading near its 52-week high with a market capitalization of $125 billion,

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his tenure.

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis Griffin, according to the announcement. The team joined LPL's core platform, affiliating with the firm in a 1099 relationship and using a shared Form ADV.

FnPS unlocks the potential for truly digital business models within and between institutions and helps accelerate transformation towards digital capital markets. Request the whitepaper Not a product of UBS research and does not constitute a financial ...

Australian shares are poised to rise with inflation data awaited. Boeing surged, Nvidia rebounded and Apple extended its recovery. Follow updates here.

US stocks slipped on Friday afternoon, with carmakers and Chinese companies leading the decline, as the White House said President Donald Trump intends to move ahead with plans on Saturday to impose 25% tariffs on Mexico and Canada and a 10% levy on China.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.95, a high estimate of $195.00, and a low estimate of $120.00. A decline of 7.58% from the prior average price target is evident in the current average.

Britain’s biggest supermarket chain used data to gain an edge, but as rivals start to catch up, Michael Fahy looks at whether its growth prospects are worth buying into